Los puntos clave no están disponibles para este artículo en este momento.
As noted in this Editor’s Page previously, the rising cost of developing new cardiovascular therapies cannot be sustained in the long-term (1)1. Accordingly, there is a critical need for new methodologies that can improve the speed, efficiency, and success rate of efforts to develop new
Foraker et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: